Dietary Supplement
walnut
walnut is a dietary supplement with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
withdrawn125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnnot_applicable
Response of Gut Microbiota and Cardiometabolic Biomarkers to Consumption of Walnuts
NCT04307628
completednot_applicable
Omega-3 and Cardiovascular Risk Factors and Kidney Related Biomarkers
NCT03197220
completednot_applicable
The Metabolic Effect of Walnut Consumption in Healthy Men and Healthy Postmenopausal Women
NCT01188902
completednot_applicable
The Mediterranean Diet and Lactation Study: A Diet Study in Lactating Women
NCT01459991
Clinical Trials (4)
Showing 4 of 4 trials
NCT04307628Not Applicable
Response of Gut Microbiota and Cardiometabolic Biomarkers to Consumption of Walnuts
NCT03197220Not Applicable
Omega-3 and Cardiovascular Risk Factors and Kidney Related Biomarkers
NCT01188902Not Applicable
The Metabolic Effect of Walnut Consumption in Healthy Men and Healthy Postmenopausal Women
NCT01459991Not Applicable
The Mediterranean Diet and Lactation Study: A Diet Study in Lactating Women
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4